Načítá se...
Update on hepatitis C: Direct-acting antivirals
Hepatitis C virus (HCV) was discovered 26 years ago. For decades, interferon-based therapy has been the mainstay of treatment for HCV. Recently, several direct-acting antivirals (DAAs) have been approved for treatment of HCV-infected patients and to help combat the virus. These drugs have revolution...
Uloženo v:
| Vydáno v: | World J Hepatol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4670954/ https://ncbi.nlm.nih.gov/pubmed/26668694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i28.2829 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|